Loading…

Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells

Patients with Down syndrome (trisomy 21, T21) have hematologic abnormalities throughout life. Newborns frequently exhibit abnormal blood counts and a clonal preleukemia. Human T21 fetal livers contain expanded erythro-megakaryocytic precursors with enhanced proliferative capacity. The impact of T21...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 2012-10, Vol.109 (43), p.17573-17578
Main Authors: Chou, Stella T, Byrska-Bishop, Marta, Tober, Joanna M, Yao, Yu, VanDorn, Daniel, Opalinska, Joanna B, Mills, Jason A, Choi, John Kim, Speck, Nancy A, Gadue, Paul, Hardison, Ross C, Nemiroff, Richard L, French, Deborah L, Weiss, Mitchell J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c558t-38680fc046042f7ee2d15affb046f87ba77280bdf80538631c4fe471926c25cd3
cites cdi_FETCH-LOGICAL-c558t-38680fc046042f7ee2d15affb046f87ba77280bdf80538631c4fe471926c25cd3
container_end_page 17578
container_issue 43
container_start_page 17573
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 109
creator Chou, Stella T
Byrska-Bishop, Marta
Tober, Joanna M
Yao, Yu
VanDorn, Daniel
Opalinska, Joanna B
Mills, Jason A
Choi, John Kim
Speck, Nancy A
Gadue, Paul
Hardison, Ross C
Nemiroff, Richard L
French, Deborah L
Weiss, Mitchell J
description Patients with Down syndrome (trisomy 21, T21) have hematologic abnormalities throughout life. Newborns frequently exhibit abnormal blood counts and a clonal preleukemia. Human T21 fetal livers contain expanded erythro-megakaryocytic precursors with enhanced proliferative capacity. The impact of T21 on the earliest stages of embryonic hematopoiesis is unknown and nearly impossible to examine in human subjects. We modeled T21 yolk sac hematopoiesis using human induced pluripotent stem cells (iPSCs). Blood progenitor populations generated from T21 iPSCs were present at normal frequency and proliferated normally. However, their developmental potential was altered with enhanced erythropoiesis and reduced myelopoiesis, but normal megakaryocyte production. These abnormalities overlap with those of T21 fetal livers, but also reflect important differences. Our studies show that T21 confers distinct developmental stage- and species-specific hematopoietic defects. More generally, we illustrate how iPSCs can provide insight into early stages of normal and pathological human development.
doi_str_mv 10.1073/pnas.1211175109
format article
fullrecord <record><control><sourceid>jstor_fao_a</sourceid><recordid>TN_cdi_fao_agris_US201600130104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>41829711</jstor_id><sourcerecordid>41829711</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-38680fc046042f7ee2d15affb046f87ba77280bdf80538631c4fe471926c25cd3</originalsourceid><addsrcrecordid>eNpdkkFv1DAQhS0EotvCmRNgiQuXtGPHiZNLJVRRQKrEgfZseR1716skDrazUv89E3bZAhdb9nzzPG_GhLxhcMlAllfTqNMl44wxWTFon5EVrqyoRQvPyQqAy6IRXJyR85R2ANBWDbwkZ7wEUUkQKzLeR5_C8Eg5K3RKwXidbUc766zJifqRbudBj3SKfvDZ7y3d2kHnMAVvk0802r3VPWbkbQzzZosZ3WzwPPVz9FPIdsw0ZTtQY_s-vSIvnO6TfX3cL8jD7ef7m6_F3fcv324-3RWmqppclE3dgDMgahDcSWt5xyrt3BpvXCPXWkrewLpzDVTIlswIZ4VkLa8Nr0xXXpDrg-40rwfbGawi6l4tLnR8VEF79W9k9Fu1CXtVipZh81Dg41Eghp-zTVkNPi0W9GjDnBR2vIK65MAQ_fAfugtzHNHebwo5xlqkrg6UiSGlaN2pGAZqmaVaZqmeZokZ7_72cOL_DA8BegSWzCe5VolSoYgsEXl7QHYph3hiBGt4K9lS-_tD3Omg9Ab_gnr4gaZqQGPA8JFfTgi5nQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1115150119</pqid></control><display><type>article</type><title>Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells</title><source>PubMed Central Free</source><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Chou, Stella T ; Byrska-Bishop, Marta ; Tober, Joanna M ; Yao, Yu ; VanDorn, Daniel ; Opalinska, Joanna B ; Mills, Jason A ; Choi, John Kim ; Speck, Nancy A ; Gadue, Paul ; Hardison, Ross C ; Nemiroff, Richard L ; French, Deborah L ; Weiss, Mitchell J</creator><creatorcontrib>Chou, Stella T ; Byrska-Bishop, Marta ; Tober, Joanna M ; Yao, Yu ; VanDorn, Daniel ; Opalinska, Joanna B ; Mills, Jason A ; Choi, John Kim ; Speck, Nancy A ; Gadue, Paul ; Hardison, Ross C ; Nemiroff, Richard L ; French, Deborah L ; Weiss, Mitchell J</creatorcontrib><description>Patients with Down syndrome (trisomy 21, T21) have hematologic abnormalities throughout life. Newborns frequently exhibit abnormal blood counts and a clonal preleukemia. Human T21 fetal livers contain expanded erythro-megakaryocytic precursors with enhanced proliferative capacity. The impact of T21 on the earliest stages of embryonic hematopoiesis is unknown and nearly impossible to examine in human subjects. We modeled T21 yolk sac hematopoiesis using human induced pluripotent stem cells (iPSCs). Blood progenitor populations generated from T21 iPSCs were present at normal frequency and proliferated normally. However, their developmental potential was altered with enhanced erythropoiesis and reduced myelopoiesis, but normal megakaryocyte production. These abnormalities overlap with those of T21 fetal livers, but also reflect important differences. Our studies show that T21 confers distinct developmental stage- and species-specific hematopoietic defects. More generally, we illustrate how iPSCs can provide insight into early stages of normal and pathological human development.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.1211175109</identifier><identifier>PMID: 23045704</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Biological Sciences ; Blood ; Cell Differentiation ; Down Syndrome ; Embryonic stem cells ; erythropoiesis ; Gene Expression Profiling ; Genes ; Hematology ; Hematopoiesis ; Hematopoiesis - genetics ; Hematopoietic stem cells ; human development ; Humans ; Induced pluripotent stem cells ; Leukemia ; Liver ; neonates ; Pathology ; patients ; Pluripotent stem cells ; Pluripotent Stem Cells - cytology ; Progenitor cells ; Real-Time Polymerase Chain Reaction ; RNA, Messenger - genetics ; Stem cells ; trisomics ; yolk sac</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17573-17578</ispartof><rights>copyright © 1993-2008 National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Oct 23, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-38680fc046042f7ee2d15affb046f87ba77280bdf80538631c4fe471926c25cd3</citedby><cites>FETCH-LOGICAL-c558t-38680fc046042f7ee2d15affb046f87ba77280bdf80538631c4fe471926c25cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/109/43.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/41829711$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/41829711$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23045704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chou, Stella T</creatorcontrib><creatorcontrib>Byrska-Bishop, Marta</creatorcontrib><creatorcontrib>Tober, Joanna M</creatorcontrib><creatorcontrib>Yao, Yu</creatorcontrib><creatorcontrib>VanDorn, Daniel</creatorcontrib><creatorcontrib>Opalinska, Joanna B</creatorcontrib><creatorcontrib>Mills, Jason A</creatorcontrib><creatorcontrib>Choi, John Kim</creatorcontrib><creatorcontrib>Speck, Nancy A</creatorcontrib><creatorcontrib>Gadue, Paul</creatorcontrib><creatorcontrib>Hardison, Ross C</creatorcontrib><creatorcontrib>Nemiroff, Richard L</creatorcontrib><creatorcontrib>French, Deborah L</creatorcontrib><creatorcontrib>Weiss, Mitchell J</creatorcontrib><title>Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Patients with Down syndrome (trisomy 21, T21) have hematologic abnormalities throughout life. Newborns frequently exhibit abnormal blood counts and a clonal preleukemia. Human T21 fetal livers contain expanded erythro-megakaryocytic precursors with enhanced proliferative capacity. The impact of T21 on the earliest stages of embryonic hematopoiesis is unknown and nearly impossible to examine in human subjects. We modeled T21 yolk sac hematopoiesis using human induced pluripotent stem cells (iPSCs). Blood progenitor populations generated from T21 iPSCs were present at normal frequency and proliferated normally. However, their developmental potential was altered with enhanced erythropoiesis and reduced myelopoiesis, but normal megakaryocyte production. These abnormalities overlap with those of T21 fetal livers, but also reflect important differences. Our studies show that T21 confers distinct developmental stage- and species-specific hematopoietic defects. More generally, we illustrate how iPSCs can provide insight into early stages of normal and pathological human development.</description><subject>Biological Sciences</subject><subject>Blood</subject><subject>Cell Differentiation</subject><subject>Down Syndrome</subject><subject>Embryonic stem cells</subject><subject>erythropoiesis</subject><subject>Gene Expression Profiling</subject><subject>Genes</subject><subject>Hematology</subject><subject>Hematopoiesis</subject><subject>Hematopoiesis - genetics</subject><subject>Hematopoietic stem cells</subject><subject>human development</subject><subject>Humans</subject><subject>Induced pluripotent stem cells</subject><subject>Leukemia</subject><subject>Liver</subject><subject>neonates</subject><subject>Pathology</subject><subject>patients</subject><subject>Pluripotent stem cells</subject><subject>Pluripotent Stem Cells - cytology</subject><subject>Progenitor cells</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>RNA, Messenger - genetics</subject><subject>Stem cells</subject><subject>trisomics</subject><subject>yolk sac</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpdkkFv1DAQhS0EotvCmRNgiQuXtGPHiZNLJVRRQKrEgfZseR1716skDrazUv89E3bZAhdb9nzzPG_GhLxhcMlAllfTqNMl44wxWTFon5EVrqyoRQvPyQqAy6IRXJyR85R2ANBWDbwkZ7wEUUkQKzLeR5_C8Eg5K3RKwXidbUc766zJifqRbudBj3SKfvDZ7y3d2kHnMAVvk0802r3VPWbkbQzzZosZ3WzwPPVz9FPIdsw0ZTtQY_s-vSIvnO6TfX3cL8jD7ef7m6_F3fcv324-3RWmqppclE3dgDMgahDcSWt5xyrt3BpvXCPXWkrewLpzDVTIlswIZ4VkLa8Nr0xXXpDrg-40rwfbGawi6l4tLnR8VEF79W9k9Fu1CXtVipZh81Dg41Eghp-zTVkNPi0W9GjDnBR2vIK65MAQ_fAfugtzHNHebwo5xlqkrg6UiSGlaN2pGAZqmaVaZqmeZokZ7_72cOL_DA8BegSWzCe5VolSoYgsEXl7QHYph3hiBGt4K9lS-_tD3Omg9Ab_gnr4gaZqQGPA8JFfTgi5nQ</recordid><startdate>20121023</startdate><enddate>20121023</enddate><creator>Chou, Stella T</creator><creator>Byrska-Bishop, Marta</creator><creator>Tober, Joanna M</creator><creator>Yao, Yu</creator><creator>VanDorn, Daniel</creator><creator>Opalinska, Joanna B</creator><creator>Mills, Jason A</creator><creator>Choi, John Kim</creator><creator>Speck, Nancy A</creator><creator>Gadue, Paul</creator><creator>Hardison, Ross C</creator><creator>Nemiroff, Richard L</creator><creator>French, Deborah L</creator><creator>Weiss, Mitchell J</creator><general>National Academy of Sciences</general><general>National Acad Sciences</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20121023</creationdate><title>Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells</title><author>Chou, Stella T ; Byrska-Bishop, Marta ; Tober, Joanna M ; Yao, Yu ; VanDorn, Daniel ; Opalinska, Joanna B ; Mills, Jason A ; Choi, John Kim ; Speck, Nancy A ; Gadue, Paul ; Hardison, Ross C ; Nemiroff, Richard L ; French, Deborah L ; Weiss, Mitchell J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-38680fc046042f7ee2d15affb046f87ba77280bdf80538631c4fe471926c25cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological Sciences</topic><topic>Blood</topic><topic>Cell Differentiation</topic><topic>Down Syndrome</topic><topic>Embryonic stem cells</topic><topic>erythropoiesis</topic><topic>Gene Expression Profiling</topic><topic>Genes</topic><topic>Hematology</topic><topic>Hematopoiesis</topic><topic>Hematopoiesis - genetics</topic><topic>Hematopoietic stem cells</topic><topic>human development</topic><topic>Humans</topic><topic>Induced pluripotent stem cells</topic><topic>Leukemia</topic><topic>Liver</topic><topic>neonates</topic><topic>Pathology</topic><topic>patients</topic><topic>Pluripotent stem cells</topic><topic>Pluripotent Stem Cells - cytology</topic><topic>Progenitor cells</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>RNA, Messenger - genetics</topic><topic>Stem cells</topic><topic>trisomics</topic><topic>yolk sac</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chou, Stella T</creatorcontrib><creatorcontrib>Byrska-Bishop, Marta</creatorcontrib><creatorcontrib>Tober, Joanna M</creatorcontrib><creatorcontrib>Yao, Yu</creatorcontrib><creatorcontrib>VanDorn, Daniel</creatorcontrib><creatorcontrib>Opalinska, Joanna B</creatorcontrib><creatorcontrib>Mills, Jason A</creatorcontrib><creatorcontrib>Choi, John Kim</creatorcontrib><creatorcontrib>Speck, Nancy A</creatorcontrib><creatorcontrib>Gadue, Paul</creatorcontrib><creatorcontrib>Hardison, Ross C</creatorcontrib><creatorcontrib>Nemiroff, Richard L</creatorcontrib><creatorcontrib>French, Deborah L</creatorcontrib><creatorcontrib>Weiss, Mitchell J</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chou, Stella T</au><au>Byrska-Bishop, Marta</au><au>Tober, Joanna M</au><au>Yao, Yu</au><au>VanDorn, Daniel</au><au>Opalinska, Joanna B</au><au>Mills, Jason A</au><au>Choi, John Kim</au><au>Speck, Nancy A</au><au>Gadue, Paul</au><au>Hardison, Ross C</au><au>Nemiroff, Richard L</au><au>French, Deborah L</au><au>Weiss, Mitchell J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2012-10-23</date><risdate>2012</risdate><volume>109</volume><issue>43</issue><spage>17573</spage><epage>17578</epage><pages>17573-17578</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Patients with Down syndrome (trisomy 21, T21) have hematologic abnormalities throughout life. Newborns frequently exhibit abnormal blood counts and a clonal preleukemia. Human T21 fetal livers contain expanded erythro-megakaryocytic precursors with enhanced proliferative capacity. The impact of T21 on the earliest stages of embryonic hematopoiesis is unknown and nearly impossible to examine in human subjects. We modeled T21 yolk sac hematopoiesis using human induced pluripotent stem cells (iPSCs). Blood progenitor populations generated from T21 iPSCs were present at normal frequency and proliferated normally. However, their developmental potential was altered with enhanced erythropoiesis and reduced myelopoiesis, but normal megakaryocyte production. These abnormalities overlap with those of T21 fetal livers, but also reflect important differences. Our studies show that T21 confers distinct developmental stage- and species-specific hematopoietic defects. More generally, we illustrate how iPSCs can provide insight into early stages of normal and pathological human development.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>23045704</pmid><doi>10.1073/pnas.1211175109</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17573-17578
issn 0027-8424
1091-6490
language eng
recordid cdi_fao_agris_US201600130104
source PubMed Central Free; JSTOR Archival Journals and Primary Sources Collection
subjects Biological Sciences
Blood
Cell Differentiation
Down Syndrome
Embryonic stem cells
erythropoiesis
Gene Expression Profiling
Genes
Hematology
Hematopoiesis
Hematopoiesis - genetics
Hematopoietic stem cells
human development
Humans
Induced pluripotent stem cells
Leukemia
Liver
neonates
Pathology
patients
Pluripotent stem cells
Pluripotent Stem Cells - cytology
Progenitor cells
Real-Time Polymerase Chain Reaction
RNA, Messenger - genetics
Stem cells
trisomics
yolk sac
title Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A20%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_fao_a&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trisomy%2021-associated%20defects%20in%20human%20primitive%20hematopoiesis%20revealed%20through%20induced%20pluripotent%20stem%20cells&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Chou,%20Stella%20T&rft.date=2012-10-23&rft.volume=109&rft.issue=43&rft.spage=17573&rft.epage=17578&rft.pages=17573-17578&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.1211175109&rft_dat=%3Cjstor_fao_a%3E41829711%3C/jstor_fao_a%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c558t-38680fc046042f7ee2d15affb046f87ba77280bdf80538631c4fe471926c25cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1115150119&rft_id=info:pmid/23045704&rft_jstor_id=41829711&rfr_iscdi=true